%0 Journal Article
%A Rodríguez-Idígoras, María I
%A Sepúlveda-Muñoz, Jesús
%A Sánchez-Garrido-Escudero, Ramón
%A Martínez-González, José L
%A Escolar-Castelló, José L
%A Paniagua-Gómez, Isabel M
%A Bernal-López, Rosa
%A Fuentes-Simón, María V
%A Garófano-Serrano, Daniel
%T Telemedicine influence on the follow-up of type 2 diabetes patients.
%D 2009
%@ 1520-9156
%U http://hdl.handle.net/10668/1155
%X OBJECTIVEThis study was designed to evaluate the impact of a teleassistance system on the metabolic control of type 2 diabetes patients.RESEARCH DESIGN AND METHODSWe conducted a 1-year controlled parallel-group trial comparing patients randomized (1) to an intervention group, assigned to a teleassistance system using real-time transmission of blood glucose results, with immediate reply when necessary, and telephone consultations, or (2) to a control group, being regularly followed-up at their healthcare center. Study subjects were type 2 diabetes patients >30 years of age followed in the primary care setting.RESULTSA total of 328 type 2 diabetes patients were recruited from 35 family practices in the province of Málaga, Spain. There was a reduction in hemoglobin A1c after 12 months from 7.62 +/- 1.60% to 7.40 +/- 1.43% (P = 0.027) in the intervention group and from 7.44 +/- 1.31% to 7.35 +/- 1.38% (P = 0.303) in the control group. The difference in the change between groups was not statistically significant. There was also a significant decrease in systolic and diastolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, and body mass index in the intervention group. In the control group, the only significant decline was in low-density lipoprotein cholesterol.CONCLUSIONSA teleassistance system using real-time transmission of blood glucose results with an option to make telephone consultations is feasible in the primary care setting as a support tool for family physicians in their follow-up of type 2 diabetes patients.
%K Glucemia
%K Diabetes Mellitus Tipo 2
%K Medicina Familiar y Comunitaria
%K Hemoglobina A Glucosilada
%K Remisión y Consulta
%K Apoyo Social
%K España
%K Telemedicina
%~